UK / AstraZeneca Changes Tack, Investing in the UK with GBP 650M Pledge
Last year the UK-based pharma industry warned against the country’s waning competitiveness, condemning the government’s statutory scheme designed to control drug prices. UK-headquartered AstraZeneca joined the battle cry, claiming it…